Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.76 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.76 |
| ▸ | THRB | P10828 | 1/20 | 0.76 |
| ▸ | BLM | P54132 | 1/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.76 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.76 |
| ▸ | CNR1 | P21554 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22758117 | 0.95 | MEN1 (0.72) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB | |
| SCHEMBL25847386 | 0.95 | MEN1 (0.72) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB | |
| SCHEMBL1456449 | 0.90 | FAAH (0.79) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB | |
| SCHEMBL1456866 | 0.90 | FAAH (0.79) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB | |
| SCHEMBL6903752 | 0.90 | FAAH (0.79) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB | |
| SCHEMBL5889532 | 0.89 | CNR2 (0.74) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB | |
| SCHEMBL375483 | 0.89 | CNR2 (0.74) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB | |
| SCHEMBL19557776 | 0.89 | ALDH1A1 (0.60) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB | |
| SCHEMBL14864043 | 0.88 | CNR2 (0.81) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB | |
| SCHEMBL3728695 | 0.86 | SLC6A5 (1.00) | CNR2SMN1; SMN2KCNK3ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109419789-B | Compound for treating and/or preventing immune disorder diseases and application thereof | 清华大学 | 2021-09-21 | — | — | CN | disclosed |
| CN-109420173-B | Application of GPR55 and regulator thereof in preventing and treating immune system diseases | 清华大学 | 2021-07-13 | — | — | CN | disclosed |
| CN-109420174-B | Application of GPR18 and regulator thereof in preventing and treating immune system diseases | 清华大学 | 2021-07-13 | — | — | CN | disclosed |
| CN-109419789-A | Treatment and/or compound and its application of epidemic prevention disorders | 清华大学 | 2019-03-05 | — | — | CN | disclosed |
| CN-109420174-A | The application of GPR18 and its regulator in prevention and treatment disease of immune system | 清华大学 | 2019-03-05 | — | — | CN | disclosed |
| CN-109420173-A | The application of GPR55 and its regulator in prevention and treatment disease of immune system | 清华大学 | 2019-03-05 | — | — | CN | disclosed |
| WO-2017053995-A1 | CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE | IONIS PHARMACEUTICALS, INC. (US) | 2017-03-30 | — | — | WO | disclosed |
| EP-1049474-A4 | CANNABIMIMETIC LIPID AMIDES AS USEFUL MEDICATIONS | UNIV CONNECTICUT (US) | 2004-12-29 | — | — | EP | disclosed |
| EP-1049474-A1 | CANNABIMIMETIC LIPID AMIDES AS USEFUL MEDICATIONS | Makriyannis, Alexandros (US) | 2000-11-08 | — | — | EP | disclosed |
| WO-2000032200-A1 | CANNABIMIMETIC LIPID AMIDES AS USEFUL MEDICATIONS | MAKRIYANNIS ALEXANDROS (US) | 2000-06-08 | — | — | WO | disclosed |